JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

C3250 Ubiquitin Isopeptidase Inhibitor I

Summary: ubiquitin isopeptidase inhibitor

≤15 mg/mL
A8740 C598-0466

Summary: USP7 inhibitor

≥40.2 mg/mL
C4090 HMB-Val-Ser-Leu-VE

Summary: inhibitor of the trypsin-like activity of the 20S proteasome

≤20 mg/mL
B1317 ML-323

Target: Deubiquitinating enzymes (DUBs)

Summary: USP1-UAF1 inhibitor
B1307 SJB3-019A

Target: USP

Summary: Usp1 inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.85 mg/mL
B1397 Trifluoperazine 2HCl

Summary: Dopamine D2 receptor inhibitor

≥24.02 mg/mL
B1395 Sulfacetamide Sodium

Summary: Sulfonamide antibiotic

≥10.65 mg/mL
B1391 Divalproex Sodium

Summary: Epilepsy/migraines/bipolar disorder medicine

≥14.2 mg/mL
A2571 Pepstatin A
1 Citation

Target: Cathepsins|Renin|HIV proteases|Pepsins

Summary: Aspartic protease inhibitor

≥34.3 mg/mL
A8179 MG-262
1 Citation

Target: Proteasome

Summary: Proteasome inhibitor

≥24.57 mg/mL